Forums and Workshops (October 8) - CET (Central European Time, GMT+01:00)
11am - Welcome and Introductions
11.05am – Capital Markets Overview
Carsten Borring, Head of Listings & Capital Markets, Nasdaq Copenhagen
Peter Legind-Hansen, Managing Director, Nasdaq Copenhagen
11.15am – Accessing US Capital & Partners
- What’s currently being seen in private investment market and the public markets
- What is being seen in the IPO and reverse merger markets in the US
- What are investors focusing on in this environment
- Focussing on core strengths and strategies for mitigating current risks
Bill Hicks, Co-chair, Securities & Capital Markets, Mintz
11.45am – Securing one of the largest Series A raises to Advance Novel Microbial Immunotherapies
Colleen Acosta, CEO, Freya Biosciences
12pm – Group Discussion, Q&A
12.20pm - End of Forum
- Carsten Borring - Head of Listings & Capital Markets, NASDAQ
- Bill Hicks - Partner, CO-Chair of Securities & Capital Markets Group, Mintz
- Colleen Acosta - Co-Founder & CEO, Freya Biosciences
13.50 Welcome and Introductions
Forum Moderator: Mike Trenell, CEO & Co-Founder, Daiser
13.55 Creative Financing Measures in a Capital-Constrained Environment
• Being creative about where you raise capital
• Crafting your message, clear understanding of your company value inflection point
• Treating every raise as a new experiment
Filip Peters, CEO, Acorai
14.05 Internationalising and Scaling Digital Health Companies
• Best practices for successful digital health business models
• Scale up challenges (financing and investment, cross border expansion etc)
Thomas Lethenborg, CEO, Monsenso
14.25 General Discussion (suggested topics to include but not limited to)
• Why hasn’t digital health succeeded yet?
• Fundraising challenges and opportunities
• Scaling digital health/ medtech start-ups
• Pathways to liquidity
• Overcoming barriers to market and regulatory approval
• Creating the right deals and partnerships to move your business forward
• Internationalising and company growth
14.50 Close CEO Forum
Nordic companies considering going public in the region are once again in the limelight. There are pros, cons, challenges and efficiencies to various approaches, which will be the focus of this workshop.
- Overview of Nordic IPO market trends and options for going public
- Approaches to listing in the Nordics
- SPACs
- Traditional IPOs
- Direct Listings
- Key considerations, benefits and challenges
- Specific considerations for dual-listed companies
- Case studies – successful company case study on going public in the Nordics
- Discussion and attendee Q&A